The ROE as of November 2024 (TTM) for Arvinas, Inc. (ARVN) is -50.26%

According to Arvinas, Inc.’s latest financial reports and current stock price. The company's current ROE is -50.26%. This represents a change of 309.49% compared to the average of -12.27% of the last 4 quarters.

Arvinas, Inc. (ARVN) Historical ROE (quarterly & annually)

How has ARVN ROE performed in the past?

The mean historical ROE of Arvinas, Inc. over the last ten years is -1255.42%. The current -50.26% ROE has changed -96.00% with respect to the historical average. Over the past ten years (40 quarters), ARVN's ROE was at its highest in in the June 2017 quarter at 0%. The ROE was at its lowest in in the December 2017 quarter at -1922.98%.

Arvinas, Inc. (ARVN) ROE by Quarter and Year

Discovering the peaks and valleys of Arvinas, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arvinas, Inc. (ARVN) Average ROE

How has ARVN ROE performed in the past?

The current ROE of Arvinas, Inc. (ARVN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Arvinas, Inc. (ARVN) ROE vs. Peers

How is ARVN’s ROE compared to its peers?

Arvinas, Inc.’s ROE is greater than C4 Therapeutics, Inc. (-42.45%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), greater than Nurix Therapeutics, Inc. (-63.39%), less than Foghorn Therapeutics Inc. (167.93%), greater than Relay Therapeutics, Inc. (-45.75%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than Pliant Therapeutics, Inc. (-48.91%), greater than Black Diamond Therapeutics, Inc. (-68.08%), greater than Shattuck Labs, Inc. (-61.92%), greater than Kymera Therapeutics, Inc. (-24.96%), greater than Ultragenyx Pharmaceutical Inc. (-187.12%), greater than Crinetics Pharmaceuticals, Inc. (-36.12%), greater than Revolution Medicines, Inc. (-33.67%), greater than Kura Oncology, Inc. (-44.09%), greater than Century Therapeutics, Inc. (-66.58%),

Build a custom stock screener for Arvinas, Inc. (ARVN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arvinas, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arvinas, Inc. (ARVN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arvinas, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.